Accrual | The Truth About Skin Care

{ Tag Archives } Accrual

Acne And Acne Care Treatment

The blockage in the minute openings of the skins by dirt is the most commonly thought about reason for acne. The majority of them are less aware of the fact that the system of toxins in the human is in addition a primary grounds for acne.
You will be in a position to find few useful [...]

Also tagged Acne Care, acne creams, Acne Cure, Acne Problems, Acne Skin care tips, Acne Solution, Acne Treatment, Bloody Meat, Capillaries, Care Solution, Chemical Substances, Emollients, get rid of acne, Harmful Toxins, Lukewarm Water, Mild Soap, natural acne treatment, Natural Elements, Protein Content, Saturated Fat, Skin Lotion, tips to cure acne, Unhealthy Diet

2010 08 06 Skin Care News Comments (0)

Provectus Reaches Milestone With Completion Of Patient Accrual In Phase 2 Trial Of PH-10 For Psoriasis

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

Also tagged Biopharmaceutical Company, Clinical Trial, Development Stage, Initial Treatment, Milestone, Oncology, Otc Bb, Pharmaceuticals Inc, Phase 10, Phase 2, Plaque Psoriasis, Provectus Pharmaceuticals, Psoriasis

2009 10 15 Skin Care News Comments Off

Provectus Pharmaceuticals Completes Patient Accrual In Initial Phase 2 Study Of PH-10 For Atopic Dermatitis

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual for its Phase 2 study of PH-10 for atopic dermatitis. PH-10 is the Company’s topical drug for the treatment of dermatologic diseases, including atopic dermatitis, a chronic skin condition that includes some forms of eczema.

Also tagged Atopic Dermatitis, Biopharmaceutical Company, Chronic Skin Condition, Dermatitis, Dermatologic Diseases, Development Stage, Eczema, Initial Phase, Oncology, Otc Bb, Pharmaceuticals Inc, Phase 2, Provectus Pharmaceuticals, Topical Drug

2009 07 02 Skin Care News Comments Off

Provectus Completes Patient Accrual In Phase 2 Trial Of PV-10 For Metastatic Melanoma

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company has completed patient accrual and initial PV-10 treatment in its Phase 2 trial of PV-10 for metastatic melanoma. The study involved treatment of 80 subjects with Stage III or Stage IV metastatic melanoma. Dr.

Also tagged Biopharmaceutical Company, Development Stage, Melanoma, Oncology, Otc Bb, Pharmaceuticals Inc, Phase 10, Phase 2, Pv, Stage Iii, Stage Iv Metastatic Melanoma

2009 05 19 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Accrual

Acne And Acne Care Treatment

Provectus Reaches Milestone With Completion Of Patient Accrual In Phase 2 Trial Of PH-10 For Psoriasis

Provectus Pharmaceuticals Completes Patient Accrual In Initial Phase 2 Study Of PH-10 For Atopic Dermatitis

Provectus Completes Patient Accrual In Phase 2 Trial Of PV-10 For Metastatic Melanoma

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: